{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,24]],"date-time":"2024-08-24T07:01:44Z","timestamp":1724482904097},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2018,11,20]],"date-time":"2018-11-20T00:00:00Z","timestamp":1542672000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1007\/s00277-018-3558-4","type":"journal-article","created":{"date-parts":[[2018,11,20]],"date-time":"2018-11-20T14:59:31Z","timestamp":1542725971000},"page":"909-914","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Early detection value of 18F-FDG-PET\/CT for drug-induced lung injury in lymphoma"],"prefix":"10.1007","volume":"98","author":[{"given":"Meixin","family":"Zhao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weifang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,11,20]]},"reference":[{"key":"3558_CR1","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s00277-017-3160-1","volume":"97","author":"T Zhou","year":"2018","unstructured":"Zhou T, Shen Q, Peng H, Chao T, Zhang L, Huang L, Yang K, Thapa S, Yu S, Jiang Y (2018) Incidence of interstitial pneumonitis in non-Hodgkin\u2019s lymphoma patients receiving immunochemotherapy with pegylated liposomal doxorubicin and rituximab. Ann Hematol 97:141\u2013147. \n                    https:\/\/doi.org\/10.1007\/s00277-017-3160-1","journal-title":"Ann Hematol"},{"key":"3558_CR2","doi-asserted-by":"publisher","first-page":"466","DOI":"10.4103\/0973-1482.204887","volume":"13","author":"I Madabhavi","year":"2017","unstructured":"Madabhavi I, Modi G, Patel A, Anand A, Panchal H, Parikh S (2017) Pulmonary toxicity following bleomycin use: a single-center experience. J Cancer Res Ther 13:466\u2013470. \n                    https:\/\/doi.org\/10.4103\/0973-1482.204887","journal-title":"J Cancer Res Ther"},{"key":"3558_CR3","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.3109\/10428194.2014.963075","volume":"56","author":"G Salmasi","year":"2015","unstructured":"Salmasi G, Li M, Sivabalasundaram V, Panzarella T, Tsang R, Kukreti V, Crump M, Kuruvilla J (2015) Incidence of pneumonitis in patients with non-Hodgkin lymphoma receiving chemoimmunotherapy with rituximab. Leuk Lymphoma 56:1659\u20131664. \n                    https:\/\/doi.org\/10.3109\/10428194.2014.963075","journal-title":"Leuk Lymphoma"},{"key":"3558_CR4","doi-asserted-by":"publisher","first-page":"613","DOI":"10.3109\/0284186X.2013.850739","volume":"53","author":"L Cella","year":"2014","unstructured":"Cella L, Liuzzi R, D'Avino V, Conson M, Di BA, Picardi M, Pugliese N, Solla R, Salvatore M, Pacelli R (2014) Pulmonary damage in Hodgkin\u2019s lymphoma patients treated with sequential chemo-radiotherapy: predictors of radiation-induced lung injury. Acta Oncol 53:613\u2013619. \n                    https:\/\/doi.org\/10.3109\/0284186X.2013.850739","journal-title":"Acta Oncol"},{"key":"3558_CR5","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1093\/annonc\/mdi232","volume":"16","author":"H Ghesquieres","year":"2005","unstructured":"Ghesquieres H (2005) Severe interstitial pneumonitis following rituximab and bleomycin-containing combination chemotherapy. Ann Oncol 16:1399. \n                    https:\/\/doi.org\/10.1093\/annonc\/mdi232","journal-title":"Ann Oncol"},{"key":"3558_CR6","doi-asserted-by":"publisher","first-page":"e120","DOI":"10.3324\/haematol.11856","volume":"92","author":"T Buchler","year":"2007","unstructured":"Buchler T, Bomanji J, Lee SM (2007) FDG-PET in bleomycin-induced pneumonitis following ABVD chemotherapy for Hodgkin\u2019s disease--a useful tool for monitoring pulmonary toxicity and disease activity. Haematologica 92:e120\u2013e121. \n                    https:\/\/doi.org\/10.3324\/haematol.11856","journal-title":"Haematologica"},{"key":"3558_CR7","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1093\/annonc\/mdj057","volume":"17","author":"I Dimopoulou","year":"2006","unstructured":"Dimopoulou I, Bamias A, Lyberopoulos P, Dimopoulos MA (2006) Pulmonary toxicity from novel antineoplastic agents. Ann Oncol 17:372\u2013379. \n                    https:\/\/doi.org\/10.1093\/annonc\/mdj057","journal-title":"Ann Oncol"},{"key":"3558_CR8","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/1465-9921-13-39","volume":"13","author":"O Matsuno","year":"2012","unstructured":"Matsuno O (2012) Drug-induced interstitial lung disease: mechanisms and best diagnostic approaches. Respir Res 13:39. \n                    https:\/\/doi.org\/10.1186\/1465-9921-13-39","journal-title":"Respir Res"},{"key":"3558_CR9","doi-asserted-by":"publisher","first-page":"2690","DOI":"10.1056\/NEJM200306263482619","volume":"348","author":"C Burton","year":"2003","unstructured":"Burton C, Kaczmarski R, Jan-Mohamed R (2003) Interstitial pneumonitis related to rituximab therapy. N Engl J Med 348:2690\u20132691; discussion 2690-2691. \n                    https:\/\/doi.org\/10.1056\/NEJM200306263482619","journal-title":"N Engl J Med"},{"key":"3558_CR10","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1007\/s10147-012-0489-2","volume":"17","author":"F Sakai","year":"2012","unstructured":"Sakai F, Johkoh T, Kusumoto M, Arakawa H, Takahashi M (2012) Drug-induced interstitial lung disease in molecular targeted therapies: high-resolution CT findings. Int J Clin Oncol 17:542\u2013550. \n                    https:\/\/doi.org\/10.1007\/s10147-012-0489-2","journal-title":"Int J Clin Oncol"},{"key":"3558_CR11","first-page":"40","volume":"33","author":"Z Mei-xin","year":"2017","unstructured":"Mei-xin Z, Wei-fang Z (2017) 18F-FDG-PET\/CT in diagnosis of chemotherapy-induced lung injury in patients with lymphoma. Chin J Med Imaging Technol 33:40\u201343","journal-title":"Chin J Med Imaging Technol"},{"key":"3558_CR12","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1056\/NEJMc1609333","volume":"375","author":"HJ Adams","year":"2016","unstructured":"Adams HJ, Kwee TC (2016) Interim PET-CT scan in advanced Hodgkin\u2019s lymphoma. N Engl J Med 375:999\u20131000. \n                    https:\/\/doi.org\/10.1056\/NEJMc1609333","journal-title":"N Engl J Med"},{"key":"3558_CR13","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s12149-007-0089-9","volume":"22","author":"T Kazama","year":"2008","unstructured":"Kazama T, Faria SC, Uchida Y, Ito H, Macapinlac HA (2008) Pulmonary drug toxicity: FDG-PET findings in patients with lymphoma. Ann Nucl Med 22:111\u2013114. \n                    https:\/\/doi.org\/10.1007\/s12149-007-0089-9","journal-title":"Ann Nucl Med"},{"key":"3558_CR14","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1080\/10428194.2016.1236379","volume":"58","author":"O Falay","year":"2017","unstructured":"Falay O, \u00d6zt\u00fcrk E, B\u00f6l\u00fckba\u015f\u0131 Y, G\u00fcm\u00fc\u015f T, \u00d6rnek S, \u00d6zbalak M, \u00c7etiner M, Demirkol O, Ferhano\u011flu B (2017) Use of fluorodeoxyglucose positron emission tomography for diagnosis of bleomycin-induced pneumonitis in Hodgkin lymphoma. Leuk Lymphoma 58:1114\u20131122. \n                    https:\/\/doi.org\/10.1080\/10428194.2016.1236379","journal-title":"Leuk Lymphoma"},{"key":"3558_CR15","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1080\/10428190802270886","volume":"49","author":"X Liu","year":"2008","unstructured":"Liu X, Hong XN, Gu YJ, Wang BY, Luo ZG, Cao J (2008) Interstitial pneumonitis during rituximab-containing chemotherapy for non-Hodgkin lymphoma. Leuk Lymphoma 49:1778\u20131783. \n                    https:\/\/doi.org\/10.1080\/10428190802270886","journal-title":"Leuk Lymphoma"},{"key":"3558_CR16","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s11523-011-0199-0","volume":"6","author":"NA Barber","year":"2011","unstructured":"Barber NA, Ganti AK (2011) Pulmonary toxicities from targeted therapies: a review. Target Oncol 6:235\u2013243. \n                    https:\/\/doi.org\/10.1007\/s11523-011-0199-0","journal-title":"Target Oncol"},{"key":"3558_CR17","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1111\/bcp.13548","volume":"84","author":"A Bonanni","year":"2018","unstructured":"Bonanni A, Calatroni M, D'Alessandro M, Signa S, Bertelli E, Cioni M, Di ME, Biassoni R, Caridi G, Ingrasciotta G, Bertelli R, Di DA, Bruschi M, Canepa A, Piaggio G, Ravani P, Ghiggeri GM (2018) Adverse events linked with the use of chimeric and humanized anti-CD20 antibodies in children with idiopathic nephrotic syndrome. Br J Clin Pharmacol 84:1238\u20131249. \n                    https:\/\/doi.org\/10.1111\/bcp.13548","journal-title":"Br J Clin Pharmacol"},{"key":"3558_CR18","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.pupt.2016.02.002","volume":"37","author":"D Franzen","year":"2016","unstructured":"Franzen D, Ciurea A, Bratton DJ, Clarenbach CF, Latshang TD, Russi EW, Kyburz D, Kohler M (2016) Effect of rituximab on pulmonary function in patients with rheumatoid arthritis. Pulm Pharmacol Ther 37:24\u201329. \n                    https:\/\/doi.org\/10.1016\/j.pupt.2016.02.002","journal-title":"Pulm Pharmacol Ther"},{"key":"3558_CR19","doi-asserted-by":"publisher","first-page":"155","DOI":"10.3349\/ymj.2008.49.1.155","volume":"49","author":"KM Kim","year":"2008","unstructured":"Kim KM, Kim HC, Jeon KN, Kim HG, Kang JH, Hahm JR, Lee GW (2008) Rituximab-CHOP induced interstitial pneumonitis in patients with disseminated extranodal marginal zone B cell lymphoma. Yonsei Med J 49:155\u2013158. \n                    https:\/\/doi.org\/10.3349\/ymj.2008.49.1.155","journal-title":"Yonsei Med J"},{"key":"3558_CR20","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1309\/AJCPAFF3RL0SABEJ","volume":"143","author":"X Zhang","year":"2015","unstructured":"Zhang X, Guo X, Pan J (2015) Increased levels of tumor necrosis factor-\u03b1 involved in rituximab-related acute pulmonary fibrosis in diffuse large B-cell lymphoma. Am J Clin Pathol 143:725\u2013727","journal-title":"Am J Clin Pathol"},{"key":"3558_CR21","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1016\/j.ejrad.2014.04.024","volume":"83","author":"M Akira","year":"2014","unstructured":"Akira M, Suganuma N (2014) Acute and subacute chemical-induced lung injuries: HRCT findings. Eur J Radiol 83:1461\u20131469. \n                    https:\/\/doi.org\/10.1016\/j.ejrad.2014.04.024","journal-title":"Eur J Radiol"},{"key":"3558_CR22","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1007\/s12149-008-0183-7","volume":"22","author":"T Yamane","year":"2008","unstructured":"Yamane T, Daimaru O, Ito S, Nagata T, Yoshiya K, Fukaya N, Ito S, Imai T, Uchida H (2008) Drug-induced pneumonitis detected earlier by 18F-FDG-PET than by high-resolution CT: a case report with non-Hodgkin\u2019s lymphoma. Ann Nucl Med 22:719\u2013722. \n                    https:\/\/doi.org\/10.1007\/s12149-008-0183-7","journal-title":"Ann Nucl Med"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-018-3558-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-018-3558-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-018-3558-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,20]],"date-time":"2019-11-20T00:11:31Z","timestamp":1574208691000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-018-3558-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,20]]},"references-count":22,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["3558"],"URL":"https:\/\/doi.org\/10.1007\/s00277-018-3558-4","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,20]]},"assertion":[{"value":"29 July 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 November 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}